Published in N Engl J Med on July 12, 1990
Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev (1996) 10.34
Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev (2003) 3.52
Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol (2004) 2.61
Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1995) 1.94
Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol (1993) 1.49
Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey. J Clin Microbiol (1996) 1.38
Isolation of a fastidious Mycobacterium species from two AIDS patients. J Clin Microbiol (1992) 1.21
Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J Clin Microbiol (1995) 1.09
Infection with a novel, unidentified mycobacterium. N Engl J Med (1990) 1.05
Etiological agents of mycobacterioses in pet birds between 1986 and 1995. J Clin Microbiol (1996) 1.04
Mycobacterium genavense infections in pet animals. J Clin Microbiol (1996) 1.02
Bias of culture techniques for diagnosing mixed Mycobacterium genavense and Mycobacterium avium infection in AIDS. J Clin Microbiol (1994) 1.02
Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol (1999) 0.99
Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods. J Clin Microbiol (1995) 0.95
Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis. J Clin Microbiol (1998) 0.92
Microaerophilic conditions promote growth of Mycobacterium genavense. J Clin Microbiol (1998) 0.92
Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures. J Clin Microbiol (1997) 0.91
Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol (1998) 0.89
Lesser known mycobacteria. J Clin Pathol (1995) 0.87
Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients. Patholog Res Int (2014) 0.86
Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography. J Clin Microbiol (1996) 0.84
Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1997) 0.84
Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient. J Clin Microbiol (2014) 0.83
Evaluation of an extended blood culture protocol to isolate fastidious organisms from patients with AIDS. J Clin Microbiol (1996) 0.81
Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense. J Clin Microbiol (1998) 0.81
Mycobacterium genavense invasive infection in two children with AIDS: long-term followup. Eur J Pediatr (1995) 0.77
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98
Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol (1990) 9.53
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (1987) 7.01
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12. Infect Immun (1987) 6.00
New method for detecting bacteriocin production. Appl Microbiol (1970) 5.42
The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell (1992) 5.24
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol (2001) 4.89
Polymerase chain reaction for the detection of Mycobacterium leprae. J Gen Microbiol (1989) 4.82
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae. Clin Exp Immunol (1984) 3.91
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Predicting high-risk years for malaria in Colombia using parameters of El Niño Southern Oscillation. Trop Med Int Health (1997) 3.39
Mycobacterial protein antigens: a compilation. Mol Microbiol (1992) 3.35
Residential culturable fungi, (1-3, 1-6)-β-d-glucan, and ergosterol concentrations in dust are not associated with asthma, rhinitis, or eczema diagnoses in children. Indoor Air (2013) 3.27
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 2.82
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature (1998) 2.82
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 2.79
Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol Respir Environ Exerc Physiol (1979) 2.68
IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol (1991) 2.64
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun (2000) 2.63
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature (1986) 2.59
Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid. Microbiology (2001) 2.47
Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur J Immunol (1987) 2.45
Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera. Clin Exp Immunol (1984) 2.32
The General Medical Council's Performance Procedures: peer review of performance in the workplace. Med Educ (2001) 2.27
The assessment of poorly performing doctors: the development of the assessment programmes for the General Medical Council's Performance Procedures. Med Educ (2001) 2.26
Evaluation of polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy for the detection of Mycobacterium tuberculosis in sputum. J Infect Dis (1992) 2.24
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev (1989) 2.22
Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest (1995) 2.20
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
Evidence-based strategies for preventing drug administration errors during anaesthesia. Anaesthesia (2004) 2.15
Characterization and distribution of Pasteurella species recovered from infected humans. J Clin Microbiol (1992) 2.12
The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes. J Exp Med (1988) 2.04
The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya. BMC Infect Dis (2005) 2.02
Accrediting research practices. Br J Gen Pract (1998) 1.97
Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol (1998) 1.94
Thymus-independent (B) cell proliferation in spleen cell cultures of mouse radiation chimeras stimulated by phytohemagglutinin or allogeneic cells. J Exp Med (1972) 1.90
Deinococcus geothermalis sp. nov. and Deinococcus murrayi sp. nov., two extremely radiation-resistant and slightly thermophilic species from hot springs. Int J Syst Bacteriol (1997) 1.88
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
Nucleic acid sequence-based amplification (NASBA) for the identification of mycobacteria. J Gen Microbiol (1993) 1.86
Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet (2006) 1.85
Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils in vivo and are ingested by the attracted granulocytes. Infect Immun (1991) 1.84
Airborne bacteria, endotoxin and fungi in dust in poultry and swine confinement buildings. Am Ind Hyg Assoc J (1983) 1.83
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol (1991) 1.78
A major immunogenic 36,000-molecular-weight antigen from Mycobacterium leprae contains an immunoreactive region of proline-rich repeats. Infect Immun (1990) 1.77
Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22--65 years. Acta Physiol Scand (1978) 1.76
Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J (1996) 1.74
A family kindred with ill-used children: the burden on the community. Br J Psychiatry (1973) 1.70
Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature (1986) 1.69
Poverty in rural areas. BMJ (1998) 1.66
Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens (1991) 1.66
Patient contact is the major determinant in incident leprosy: implications for future control. Int J Lepr Other Mycobact Dis (1999) 1.65
Susceptibility of beige mice to Mycobacterium avium: role of neutrophils. Infect Immun (1995) 1.63
The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol (1995) 1.62
Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence. J Clin Densitom (2000) 1.60
Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol (2003) 1.60
Effects of age on enzyme-histochemical fibre spectra and contractile properties of fast- and slow-twitch skeletal muscles in the rat. J Neurol Sci (1986) 1.59
TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur Cytokine Netw (1994) 1.56
T cell-dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol (1989) 1.56
High prevalence of asthma in cross country skiers. BMJ (1993) 1.56
Isolation of mycobacteria from healthy persons' stools. Int J Lepr Other Mycobact Dis (1988) 1.55
Forecasting disease risk for increased epidemic preparedness in public health. Adv Parasitol (2000) 1.54
Detection of alcohols and volatile fatty acids by head-space gas chromatography in identification of anaerobic bacteria. J Clin Microbiol (1978) 1.52
Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J Immunol (2001) 1.52
Separation among species of Mycobacterium terrae complex by lipid analyses: comparison with biochemical tests and 16S rRNA sequencing. J Clin Microbiol (1998) 1.51
Assessment of mycobacterial viability by RNA amplification. Antimicrob Agents Chemother (1994) 1.51
Light emitting diodes for auramine O fluorescence microscopic screening of Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2006) 1.50
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med (1990) 1.48
Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol (1994) 1.47
Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res (1997) 1.47
Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys (2000) 1.47
Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med (1996) 1.46
Contractile studies of single human skeletal muscle fibers: a comparison of different muscles, permeabilization procedures, and storage techniques. Muscle Nerve (1997) 1.46
Do radiologists still need to report chest x rays? Postgrad Med J (2009) 1.43
Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation. Anesth Analg (1998) 1.43
Simian virus 40 t antigen affects the sensitivity of cellular DNA synthesis to theophylline. J Virol (1979) 1.43
Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol (1996) 1.43
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42
Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathog (1990) 1.42
Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol (1988) 1.40
Gastric intramural pH as indicator of early allograft viability in orthotopic liver transplantation. Transplantation (1994) 1.39
Radiation therapy treatment verification imaging in Australia and New Zealand. J Med Imaging Radiat Oncol (2008) 1.38
Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol (1985) 1.38
Changes in hip fracture epidemiology: redistribution between ages, genders and fracture types. Osteoporos Int (2002) 1.38
Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37
Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health (2004) 1.37
Gas chromatographic characterization of mycobacteria: analysis of fatty acids and trifluoroacetylated whole-cell methanolysates. J Clin Microbiol (1976) 1.36
Demonstration of tuberculostearic acid in sputum from patients with pulmonary tuberculosis by selected ion monitoring. J Clin Invest (1979) 1.36
Simple colorimetric microtiter plate hybridization assay for detection of amplified Mycobacterium leprae DNA. J Clin Microbiol (1993) 1.35
Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun (1994) 1.35
An exosporium-like outer layer in Bacillus subtilis spores. Nature (1976) 1.34
Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J (1997) 1.34